Overview
Lobbying Costs
1,000,000€ - 1,249,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
4.55 Fte (10)
Lobbyists with EP accreditation
8
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
Bristol-Myers Squibb Company (BMS)
EU Transparency Register
04437556781-76 First registered on 26 Sep 2011
Goals / Remit
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Main EU files targeted
Implementation of the Pharmaceutical Strategy for Europe (including Regulation 2023/0131 for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency and Directive 2023/0123 on the Union code relating to medicinal products for human use), Fees payable to the European Medicines Agency, Revision of the OMP and Paediatric Regulations, implementation of the EU Regulation on HTA, Clinical Trials legislation, Europe's Beating Cancer Plan, Regulation on a European Health Data Space, Access to medicines, Standards of quality and safety for substances of human origin intended for human application, IP Action, Plan, EU Reference networks, cross-country collaboration on pricing and access to medicines, European Semester, trade agreements, Transatlantic Data flows, GDPR, data analytics including AI, a new transatlantic agenda, Healthier Together (EU NCD Initiative)
Address
Head Office
Park Avenue, 345
New York, NY 10154
UNITED STATESEU Office
Rue du Trône 108
Ixelles 1050
BELGIUMWebsite
-
People
Total lobbyists declared
10
Employment time Lobbyists 100% 2 75% 1 50% 2 25% 2 10% 3 Lobbyists (Full time equivalent)
4.55
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
8 accreditations were / are live (in bold) for the selected state of 19 Apr 2024
Name Start date End Date Claire ALBANO 15 Nov 2023 14 Nov 2024 Sara Lynn MARTIN 10 Nov 2023 08 Nov 2024 Silviu POPA 05 Oct 2023 04 Oct 2024 Katerina VALKOVA 13 Feb 2024 12 Feb 2025 Pieter Jan MATTHEUS 05 Oct 2023 04 Oct 2024 Douglas GREGORY 13 Jul 2023 12 Jul 2024 Dimitri Pouradier Duteil 06 Oct 2023 04 Oct 2024 Ms Katerina VALKOVA 13 Feb 2024 15 Apr 2024 Ms Claire Albano 15 Nov 2023 15 Apr 2024 Ms Sara Lynn Martin 10 Nov 2023 15 Apr 2024 Emmanuel CHANTELOT 21 Oct 2023 18 Oct 2024 Mr Dimitri Pouradier Duteil 06 Oct 2023 15 Apr 2024 Mr Silviu Popa 05 Oct 2023 15 Apr 2024 Mr Pieter Jan MATTHEUS 05 Oct 2023 15 Apr 2024 Mr Douglas GREGORY 13 Jul 2023 15 Apr 2024 Mr Bernard MALLEE 13 Apr 2023 15 Apr 2024 Ms Claire Albano 19 Nov 2022 15 Nov 2023 Mr Adam David PARNABY 17 Nov 2022 13 Apr 2023 Ms Sara Lynn Martin 16 Nov 2022 10 Nov 2023 Emmanuel CHANTELOT 27 Oct 2022 21 Oct 2023 Mr Pieter Jan MATTHEUS 14 Oct 2022 05 Oct 2023 Mr Silviu Popa 13 Oct 2022 05 Oct 2023 Mr Dimitri Pouradier Duteil 12 Oct 2022 06 Oct 2023 Mr Silviu Popa 28 Oct 2021 13 Oct 2022 Ms Katerina VALKOVA 06 Oct 2022 06 Oct 2023 Mr Douglas GREGORY 22 Jun 2022 22 Jun 2023 Ms Anneke SANDERS 30 Mar 2022 02 Apr 2022 Ms Claire Albano 18 Dec 2021 19 Nov 2022 Mr Pieter Jan MATTHEUS 19 Nov 2021 14 Oct 2022 Emmanuel CHANTELOT 04 Nov 2021 27 Oct 2022 Silviu POPA 28 Oct 2021 11 Oct 2022 Ms Sara MARTIN 28 Oct 2021 28 Oct 2022 Mr Dimitri Pouradier Duteil 28 Oct 2021 12 Oct 2022 Mr Douglas GREGORY 17 Jun 2021 17 Jun 2022 Mr Douglas GREGORY 24 Jun 2020 17 Jun 2021 Ms Titta Rosvall-Puplett 15 Feb 2020 01 Mar 2021 Mr Dimitri Pouradier Duteil 15 Feb 2020 01 Mar 2021 Ms Sara MARTIN 15 Feb 2020 01 Mar 2021 Ms Sara MARTIN 16 Feb 2019 15 Feb 2020 Ms Titta Rosvall-Puplett 13 Feb 2019 13 Feb 2020 Mr Dimitri Pouradier Duteil 13 Feb 2019 13 Feb 2020 Ms Laurence Leclercq 13 Feb 2019 13 Feb 2020 Ms Laurence Leclercq 16 Feb 2018 13 Feb 2019 Ms Titta Rosvall-Puplett 15 Feb 2018 13 Feb 2019 Ms Danuta Rydlewska 15 Feb 2018 16 Feb 2019 Mr Dimitri Pouradier Duteil 15 Feb 2018 13 Feb 2019 Ms Titta Rosvall-Puplett 20 Mar 2017 15 Feb 2018 Ms Danuta Rydlewska 20 Mar 2017 15 Feb 2018 Mr Dimitri Pouradier Duteil 20 Mar 2017 15 Feb 2018 Mr Martin Whitehead 05 Sep 2016 01 Sep 2017 Ms Danuta Rydlewska 30 Mar 2016 21 Mar 2017 Ms Titta Rosvall-Puplett 24 Mar 2016 10 Mar 2017 Mr Dimitri Pouradier Duteil 13 Feb 2016 12 Feb 2017 Ms Anouk De Vroey 25 Sep 2015 23 Sep 2016 Ms Titta Rosvall-Puplett 11 Feb 2015 05 Feb 2016 Ms Anouk De Vroey 16 Sep 2014 12 Sep 2015 Mrs Anouk DE VROEY 16 Sep 2014 27 Jan 2015 Mr Jean-Louis Roux 16 Sep 2014 12 Sep 2015 Mr Jean-Louis Roux 01 Oct 2013 16 Sep 2014 Ms Athanasia Kanli 28 Sep 2013 27 Sep 2014 Mrs Anouk DE VROEY 26 Sep 2013 16 Sep 2014 Mrs Anouk DE VROEY 28 Nov 2011 01 Nov 2012 Complementary Information
1 Head of International Policy and Government Affairs (10%)
1 Senior Director, EU Government Affairs Strategy and Excellence (90%)
1 Director European Government Affairs (50%)
1 Associate Director, European Public Policy (90%)
1 Director, Government Engagement and Partnerships, Europe (50%)
1 Director, International Government Affairs Excellence (10%)
1 Associate Director, Policy & Government Affairs - Intercontinental (10%)
1 Senior Director, Health Policy, Strategy and Economics (25%)
1 Senior Director, Global Policy Partnerships & Alliance Development (10%)
1 Director, International Policy Communications (50%)
Other BMS employees contributing to EU policy-shaping through participation in trade association working groups are accounted for in the total expenses, but not in the FTE above. The above covers only Brussels-based policy & government affairs staff.Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
European Federation of Pharmaceutical Industries and Associations (EFPIA), EFPIA Oncology Platform, EFPIA Cardiovascular Health Platform, DigitalEurope, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Friends of Europe, American Chamber of Commerce to the EU, American European Community Association (AECA), American Chamber of Commerce Turkey, European Patients' Forum, EURORDIS, TRANSFORM Alliance
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
1,000,000€ - 1,249,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount zn consulting 100,000€ - 199,999€ apco 50,000€ - 99,999€ acumen public affairs 50,000€ - 99,999€ dentons global advisors 400,000€ - 499,999€ eppa 25,000€ - 49,999€ Intermediaries for current year
Name acumen public affairs dga interel apco zn consulting Closed year Costs
1,000,000€ - 1,249,999€
Other financial info
Bristol-Myers Squibb Belgium has a corporate sponsorship with the Alliance of Liberals and Democrats for Europe for 2023. The amount of that corporate sponsorship is 18,000 euros and it is treated as a political donation.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
BMS is a member and main sponsor of the All.Can initiative https://www.all-can.org/about-us/
Towards sustainable Cancer Care : Reducing Inefficiencies, improving outcomes - A policy Report from the All.Can initiative - January 2017
Blood and Beyond https://bloodandbeyond.com/
including launch event held on Thursday, March 26, 2020 and report on "Rethinking Blood Use in Europe to Improve Outcomes for" published on March 26, 2020
Cardiomyopathies Matter cardiomyopathiesmatter.org
Including launch event on November 15, 2022 in the European Parliament and report published the same day.
BMS EU Policy Twitter handle (@BMS_EUpolicy) and BMS EU policy website (www.eupolicy.bms.com) launched in January 2023Other activities
None declared
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 08 Dec 2016 Location Brussels Subject Innovation and investment Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Juho Romakkaniemi (Cabinet member)
-
Date 08 Dec 2016 Location Brussels Subject HTA, HSPA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)